Drug screening and ation testing for suspected drug use in service member investigative and/or post-mortem urine, blood and tissue samples.
Ended Awarded
- Contract number
- HT009025FG0310021
- Awardee
-
Cerilliant Corporation UEI JDDKSJ34EBZ7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $22,803
Award facts
- Contract value 100% obligated
- $22,803.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Round Rock, TX 78665, USA
Award details come from SAM.gov/FPDS.
About this award
This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a global manufacturer of certified reference materials and analytical standards. The contract, valued at $22,803.21, is for the provision of drug screening and confirmation testing services for suspected drug use in service member investigative and/or post-mortem urine, blood, and tissue samples. The contract has an ultimate completion date of September 30, 2025.
Cerilliant Corporation, a foreign-owned, for-profit manufacturer based in Round Rock, Texas, has extensive experience serving as a prime contractor and subcontractor to various federal agencies, including the DHA, Centers for Disease Control and Prevention (CDC), and National Institutes of Health (NIH). The company has multiple Blanket Purchase Agreements (BPAs) with the DHA and Army Medical Command to supply drug reference standards, medical and laboratory supplies, and other analytical products. This contract was awarded without a set-aside designation, reflecting Cerilliant's unique capabilities in the production and supply of certified reference materials for government healthcare, research, and testing initiatives.
Quick answers
Who was awarded contract HT009025FG0310021?
HT009025FG0310021 was awarded to Cerilliant Corporation by Defense Health Agency (Department of Defense) on March 4, 2025.
How much is contract HT009025FG0310021 worth?
The government has obligated $22,803 on HT009025FG0310021.
Is contract HT009025FG0310021 an order under another contract?
Yes. HT009025FG0310021 is a BPA call under HT942523A0001, a blanket purchase agreement.
Was contract HT009025FG0310021 competed?
The extent of competition for HT009025FG0310021 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award